121 related articles for article (PubMed ID: 1117187)
1. Letter: Evaluation of atrophy production and vasoconstrictor potency in humans following intradermally injected corticosteroids.
Smith EB
J Invest Dermatol; 1975 Apr; 64(4):277. PubMed ID: 1117187
[No Abstract] [Full Text] [Related]
2. Evaluation of atrophy production and vasoconstrictor potency in humans following intradermally injected corticosteroids.
Snyder DS; Greenberg RA
J Invest Dermatol; 1974 Dec; 63(6):461-3. PubMed ID: 4430856
[No Abstract] [Full Text] [Related]
3. Letter: Perilymphatic atrophy of the skin.
Kikuchi I; Horikawa S
Arch Dermatol; 1975 Jun; 111(6):795-6. PubMed ID: 1137430
[No Abstract] [Full Text] [Related]
4. Local subcutaneous atrophy after corticosteroid injection.
Jacobs MB
Postgrad Med; 1986 Sep; 80(4):159-60. PubMed ID: 3763512
[TBL] [Abstract][Full Text] [Related]
5. Systemic steroid therapy with intramuscularly injected triamcinolone.
Arnold HL
South Med J; 1978 Feb; 71(2):102-7. PubMed ID: 622614
[No Abstract] [Full Text] [Related]
6. Ultrasonic assessment of cutaneous atrophy caused by intradermal corticosteroids.
Gomez EC; Berman B; Miller DL
J Dermatol Surg Oncol; 1982 Dec; 8(12):1071-4. PubMed ID: 7153406
[TBL] [Abstract][Full Text] [Related]
7. Axillary and inguinal striae induced by systemic absorption of a topical corticosteroid.
Sorensen GW; Odom RB
Cutis; 1976 Feb; 17(2):355-7. PubMed ID: 1017240
[TBL] [Abstract][Full Text] [Related]
8. Intralesional corticosteroids.
Callen JP
J Am Acad Dermatol; 1981 Feb; 4(2):149-51. PubMed ID: 7217384
[TBL] [Abstract][Full Text] [Related]
9. [Comparative studies on the vasoconstrictor effect of various corticosteroids].
Bickhardt R
Hautarzt; 1972 Jul; 23(7):301-5. PubMed ID: 4655109
[No Abstract] [Full Text] [Related]
10. Letter: Withdrawal of corticosteroids.
Arnold HL
Lancet; 1976 Jan; 1(7951):149. PubMed ID: 54664
[No Abstract] [Full Text] [Related]
11. Dermatrophy from long-term occulsive topical corticosteroid therapy.
Goette DK
South Med J; 1973 May; 66(5):542-6. PubMed ID: 4698761
[No Abstract] [Full Text] [Related]
12. [Stop intra-disk injections of corticosteroids].
Bontoux D
Rev Rhum Mal Osteoartic; 1992 Feb; 59(2):87-9. PubMed ID: 1604234
[No Abstract] [Full Text] [Related]
13. Treatment of local, persistent cutaneous atrophy following corticosteroid injection with normal saline infiltration.
Shumaker PR; Rao J; Goldman MP
Dermatol Surg; 2005 Oct; 31(10):1340-3. PubMed ID: 16188192
[TBL] [Abstract][Full Text] [Related]
14. Skin and fat atrophy complications of local steroid injection.
Di Stefano V; Nixon JE
Pa Med; 1974 Jan; 77(1):38. PubMed ID: 4809750
[No Abstract] [Full Text] [Related]
15. Evaluation of the efficacy of topical corticosteroids.
Zaynoun ST; Kurban AK
Br J Dermatol; 1974 Jan; 90(1):85-90. PubMed ID: 4811838
[No Abstract] [Full Text] [Related]
16. Adverse effects of corticosteroids.
Goette DK; Odom RB
Cutis; 1979 Apr; 23(4):477-87. PubMed ID: 154995
[TBL] [Abstract][Full Text] [Related]
17. Intralesional steroids in dermatophytosis: Quackery in India takes new route.
Srivastava A; Agrawal S
Indian J Dermatol Venereol Leprol; 2019; 85(5):568. PubMed ID: 30504531
[No Abstract] [Full Text] [Related]
18. Subacromial triamcinolone acetonide, hyaluronic acid and saline injections for shoulder pain an RCT investigating the effectiveness in the first days.
Penning LI; de Bie RA; Walenkamp GH
BMC Musculoskelet Disord; 2014 Oct; 15():352. PubMed ID: 25341673
[TBL] [Abstract][Full Text] [Related]
19. Extemporaneous formulation of corticosteroids for topical usage.
Burdick KH; Poulsen B; Place VA
JAMA; 1970 Jan; 211(3):462-6. PubMed ID: 5466919
[No Abstract] [Full Text] [Related]
20. The effects of intradermal steroids on the pituitary-adrenal axis and the skin.
Jarratt MT; Spark RF; Arndt KA
J Invest Dermatol; 1974 Apr; 62(4):463-6. PubMed ID: 4820688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
